Data / Form D filings / PIERIS PHARMACEUTICALS, INC.
PIERIS PHARMACEUTICALS, INC.: Form D filings
PIERIS PHARMACEUTICALS, INC., a pharmaceuticals company in Boston, MA, filed 4 Form D notices with the SEC between 2014 and 2019. The latest, on November 20, 2019, reports $32 million sold of a $32 million offering to 9 investors.
Find out what PIERIS PHARMACEUTICALS, INC. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 255 STATE STREET, 9TH FLOOR, Boston, MA, 02109
- Phone
- (857) 246-8998
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Nevada
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1583648
The full lists. Form D filings in Massachusetts: 1,533 rows, $76.65, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 20, 2019 | New notice | $32,003,108 | $32,003,108 | $0 | 9 | Nov 6, 2019 | sec.gov |
| Jun 15, 2016 | New notice | $16,500,440 | $16,500,440 | $0 | 15 | Jun 2, 2016 | sec.gov |
| Dec 31, 2014 | New notice | $13,559,020 | $13,559,020 | $0 | 139 | Dec 17, 2014 | sec.gov |
| Dec 31, 2014 | New notice | $40,000,000 | $40,000,000 | $0 | 21 | Dec 17, 2014 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Stephen S. Yoder | Executive Officer, Director | |
| Ahmed S. Mousa | Executive Officer | |
| James S. Geraghty | Director | |
| Michael S. Richman | Director | |
| Ann S. Barbier, M.D., Ph.D. | Director | |
| Hitto R. Kaufmann, Ph.D. | Executive Officer | |
| Christopher S. Kiritsy | Director | |
| Peter S. Kiener, D.Phil. | Director | |
| Matthew L. Sherman, M.D. | Director | |
| Maya R. Said, Sc.D. | Director | |
| Tom R. Bures | Executive Officer | |
| Jean-Pierre S. Bizzari, M.D. | Director |
Other pharmaceuticals companies in Massachusetts that filed recently
- BridgeHealth Pharmaceuticals, Inc. $3.5 million · Nov 5, 2026
- Land Therapeutics Inc. $17.5 million · Oct 21, 2026
- Crosslink Therapeutics Inc. $5.5 million · Oct 20, 2026
- Sentonix, Inc. $12.7 million · Aug 20, 2026
Every Form D from the week of Nov 18, 2019 · All recent filings in Massachusetts · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what PIERIS PHARMACEUTICALS, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.